Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-05

Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir

View source ↗

Summary

A clinical trial evaluating pharmacokinetics, pharmacodynamics and cervicovaginal lavage of combined oral contraceptives with raltegravir for HIV has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined oral contraceptives
  • Raltegravir (raltegravir)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV | Status: WITHDRAWN